# A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects

> **NCT03627845** · PHASE1 · COMPLETED · sponsor: **pH Pharma** · enrollment: 49 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** PHP-303
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03627845
- **Lead sponsor:** pH Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-02
- **Primary completion:** 2018-12-05
- **Final completion:** 2020-01-08
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2020-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03627845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03627845, "A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03627845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*